Literature DB >> 2961580

The D-2 agonist quinpirole releases striatal dopamine in vivo.

T Sharp1, T Zetterström, A K Collin, U Ungerstedt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2961580     DOI： 10.1016/0014-2999(87)90675-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  4 in total

1.  Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Neural Transm Gen Sect       Date:  1989

2.  D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine.

Authors:  H Ujike; K Akiyama; S Otsuki
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.

Authors:  S B Ross; D M Jackson; E M Wallis; S R Edwards
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

4.  Neural bases for attenuation of morphine withdrawal by Heantos-4: role of l-tetrahydropalmatine.

Authors:  Soyon Ahn; Maya O Nesbit; Haiyan Zou; Giada Vacca; Peter Axerio-Cilies; Tran Van Sung; Anthony G Phillips
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.